Cracking the Code: Relieving Tiny Lungs From the Grip of RSV - Mona Hemmati

Year
2025
Tags
RSV
respiratory syncytial virus
pediatric health
viral infection
antiviral therapy
protein interactions
drug discovery
artificial intelligence in biology
molecular biology
childhood disease
respiratory disease
translational research
biomedical science
Canberra
Summary

Respiratory Syncytial Virus (RSV) hospitalises thousands of children each year, yet effective treatments remain unavailable. This research investigates a critical protein–protein interaction that enables RSV infection. By identifying and disrupting key molecular binding sites using AI, the work aims to support the development of targeted antiviral therapies for severe RSV.